Novo Nordisk A/S (NVO)
132.41
+3.99
(+3.11%)
USD |
NYSE |
May 13, 16:00
132.36
-0.05
(-0.04%)
After-Hours: 20:00
Novo Nordisk Price to Book Value: 41.22 for May 13, 2024
Price to Book Value Chart
Historical Price to Book Value Data
Date | Value |
---|---|
May 10, 2024 | 39.98 |
May 09, 2024 | 40.06 |
May 08, 2024 | 39.45 |
May 07, 2024 | 39.63 |
May 06, 2024 | 38.79 |
May 03, 2024 | 38.37 |
May 02, 2024 | 38.67 |
May 01, 2024 | 40.29 |
April 30, 2024 | 40.01 |
April 29, 2024 | 39.56 |
April 26, 2024 | 39.55 |
April 25, 2024 | 39.22 |
April 24, 2024 | 39.34 |
April 23, 2024 | 40.11 |
April 22, 2024 | 39.06 |
April 19, 2024 | 38.26 |
April 18, 2024 | 38.28 |
April 17, 2024 | 38.83 |
April 16, 2024 | 38.49 |
April 15, 2024 | 38.63 |
April 12, 2024 | 38.82 |
April 11, 2024 | 39.10 |
April 10, 2024 | 38.96 |
April 09, 2024 | 38.94 |
April 08, 2024 | 39.75 |
Date | Value |
---|---|
April 05, 2024 | 39.25 |
April 04, 2024 | 38.66 |
April 03, 2024 | 39.60 |
April 02, 2024 | 39.44 |
April 01, 2024 | 39.78 |
March 31, 2024 | |
March 28, 2024 | 36.21 |
March 27, 2024 | 36.11 |
March 26, 2024 | 36.50 |
March 25, 2024 | 36.40 |
March 22, 2024 | 36.31 |
March 21, 2024 | 36.62 |
March 20, 2024 | 36.77 |
March 19, 2024 | 37.05 |
March 18, 2024 | 37.48 |
March 15, 2024 | 37.33 |
March 14, 2024 | 37.96 |
March 13, 2024 | 37.65 |
March 12, 2024 | 38.11 |
March 11, 2024 | 37.02 |
March 08, 2024 | 37.53 |
March 07, 2024 | 38.34 |
March 06, 2024 | 35.19 |
March 05, 2024 | 35.16 |
March 04, 2024 | 36.09 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
13.44
Minimum
Mar 20 2020
41.22
Maximum
May 13 2024
22.94
Average
21.92
Median
Sep 16 2022
Price to Book Value Benchmarks
Amgen Inc | 32.94 |
AstraZeneca PLC | 6.412 |
GSK PLC | 5.271 |
Viking Therapeutics Inc | 8.549 |
Evaxion Biotech AS | -- |
Price to Book Value Related Metrics
PE Ratio | 45.70 |
PS Ratio | 16.71 |
PEG Ratio | 0.8652 |
Price to Free Cash Flow | 80.99 |
Price | 132.41 |
Earnings Yield | 2.19% |
Market Cap | 589.86B |
PEGY Ratio | 0.8480 |
Operating PE Ratio | 37.28 |
Normalized PE Ratio | 45.70 |